Associated Papers
CDK6 activity in a recurring convergent kinase network motif.
Gangemi CG et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2023
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.
Li Q et al.
Cancer Discovery, 2022
A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity.
Nataraj SE et al.
Cell Cycle (georgetown, Tex.), 2021
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Xue Y et al.
Nature Communications, 2019
CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.
Dall'Acqua A et al.
Embo Molecular Medicine, 2017
Select a paper to view details